According to IMARC Group’s latest report, titled “Influenza Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global influenza vaccine market size reached a value of US$ 5.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2027, exhibiting a CAGR of 7.9% during 2022-2027.
Influenza vaccines, also known as flu shots, provide protection against various types of influenza viruses. They are available in several options, including inactivated influenza vaccine [IIV], recombinant influenza vaccine [RIV], and live attenuated influenza vaccine (LAIV). Their effectiveness can vary, depending on the patient’s age and health status. Presently, governments of numerous countries have mandated immunization against influenza among children between six months and five years of age. This is escalating the need for influenza vaccines to reduce the high risk of developing severe flu complications and hospitalization among infants around the world.
COVID-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/influenza-vaccine-market/requestsample
Influenza Vaccine Market Trends:
The rising prevalence of diabetes, cancer, anemia, obesity, immune deficiencies, human immunodeficiency virus (HIV), metabolic diseases, kidney disease, neurological disorder, and chronic heart and lung disorders, such as bronchopulmonary dysplasia, cystic fibrosis, and asthma, is increasing the risk of developing influenza. This acts as a major factor bolstering the market growth. In addition, children under five years of age are usually at a high risk of complications from high fever, convulsions, and pneumonia. This, in confluence with growing concerns among parents about the well-being of their children, is positively influencing the demand for influenza vaccines. Moreover, as immune systems decline with age, the rising geriatric population worldwide is catalyzing the demand for influenza vaccines to prevent serious illness, the need for hospitalization, and the possibility of a heart attack. Several vaccines are also available that help boost immune response in adults over sixty-five years. Besides this, health agencies of numerous countries are introducing free seasonal influenza vaccination programs for people of all age groups, which is creating a positive outlook for the market.
Influenza Vaccine Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the influenza vaccine market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abbott Laboratories
- AstraZeneca plc
- CSL Limited
- Daiichi Sankyo Company Limited
- Emergent BioSolutions Inc.
- F. Hoffmann-La Roche AG
- Gamma Vaccines Pty Ltd
- GlaxoSmithKline plc
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- SINOVAC
Key Market Segmentation:
The report has segmented the influenza vaccine market on the basis of breakup by vaccine type, technology, age group, route of administration and region.
Breakup by Vaccine Type:
- Quadrivalent
- Trivalent
Breakup by Technology:
- Egg-based
- Cell-based
Breakup by Age Group:
- Pediatric
- Adult
Breakup by Route of Administration:
- Injection
- Nasal Spray
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Turkey, South Africa, Others)
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/influenza-vaccine-market
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800